We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Structural and Functional Insights into GPCR Signalling
-
1. Structural basis of LSD signaling
- Dr. Daniel Wacker
-
3. Structural and mechanistic insights into the neurotensin receptor
- Dr. Reinhard Grisshammer
-
5. Biology and structure of arrestin proteins
- Prof. Vsevolod V. Gurevich
-
6. Structure and function of adhesion GPCRs and their ligands
- Prof. Demet Araç
- GPCR signalling in human health and disease
-
7. Pre-coupling of receptor oligomers and signaling molecules
- Dr. Sergi Ferré
-
9. G proteins and the biology of depression and antidepressants
- Prof. Mark M. Rasenick
-
10. GPCRs and pain
- Prof. Dr. Christoph Stein
-
11. Adhesion GPCRs in nervous system development and disease
- Prof. Tobias Langenhan
-
12. G proteins and GPCRs in cancer
- Prof. J. Silvio Gutkind
- Methods to Study GPCRs and Applications of GPCR Engineering
-
13. Computational modelling of GPCR signalling dynamics
- Dr. Graham Ladds
-
14. Super-resolution imaging of GPCR oligomers: applications and functional roles
- Dr. Aylin Hanyaloglu
-
15. Applications of mini G proteins to study G protein-coupled receptors
- Dr. Byron Carpenter
-
16. What can we learn from conformational profiling of GPCRs?
- Prof. Terry Hébert
- GPCR Drug Discovery
-
17. Drugging conformational states of GPCRs
- Prof. Dr. Peter Kolb
-
18. Conserved allosteric sodium in class A GPCRs: GPCR structure and allosteric effects
- Dr. Vsevolod “Seva” Katritch
-
19. Conserved allosteric sodium in class A GPCRs: Na+ dynamics in GPCR signaling
- Dr. Vsevolod “Seva” Katritch
-
20. Biased signaling at mu opioid receptor splice variants
- Prof. Ying-Xian Pan
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- G protein-coupled receptors (GPCRs)
- Structure determination of GPCRs
- Structure determination of active-state GPCRs
- Development of mini G proteins
- Isolation of the Gαs-GTPase domain (mini-Gs)
- Engineering mini-Gs
- Properties of mini-Gs
- Different classes of mini G proteins
- Mini G protein chimeras
- In vitro assays
- Applications in structural biology (1)
- Applications in structural biology (2)
- Crystallising the A2AR–mini-Gs complex
- Purification of the A2AR–mini-Gs complex
- Crystallisation and data collection
- A2AR–mini-Gs complex
- A2AR conformational changes
- Rearrangements in the core of A2AR
- A2AR ligand-binding pocket
- GPCR–G protein interface
- Functional studies
- Summary
- Acknowledgements
- Full references for reproduced figures
Topics Covered
- Structure determination of G protein-coupled receptors (GPCRs) in their active state
- Development of engineered mini G proteins
- Applications of mini G proteins in GPCR structural studies
- Crystallisation of the human adenosine A2A receptor in complex with a mini G protein
- Applications of mini G proteins in GPCR functional studies
Links
Series:
Categories:
Talk Citation
Carpenter, B. (2020, January 30). Applications of mini G proteins to study G protein-coupled receptors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved August 31, 2024, from https://doi.org/10.69645/HFKD9474.Export Citation (RIS)
Publication History
Financial Disclosures
- Commercial/Financial matters disclosed are that Byron Carpenter is an inventor on a patent application related to mini G proteins filed by Heptares Therapeutics Ltd.
A selection of talks on Cell Biology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Byron Carpenter and I'm a Research Fellow at the University of Warwick.
This lecture will cover the development of mini-G proteins and
their applications to study the structure and function of G protein-coupled receptors.
0:13
I'll begin this presentation with an introduction to G protein-coupled receptors,
which would be referred to as GPCRs from now on.
Next, I'll give an overview of the development of mini G proteins,
I'll then cover the applications in GPCR structural biology.
As a case study, I'll look at the crystallization of
the adenosine A2A receptor in complex with mini-G protein.
I'll then talk about their applications in GPCR functional studies,
and finally I'll end with a summary of our findings.
0:42
GPCRs are cell surface receptors that regulate many aspects of eukaryotic cell behavior.
Their role is to recognize extracellular signaling molecules and transmit
this information across the cell membrane to activate intracellular signaling cascades.
There are over 400 nonolfactory GPCRs in
the human genome and they recognize a wide variety of different signaling molecules,
including small molecule hormones such as adrenaline,
peptides such as neurotensin,
and multi-chain glycoproteins such as
the follicle stimulating hormone as shown at the top of the slide.
When an agonist binds to a receptor,
it initiates a subtle conformational and energetic changes that are
propagated to its cytoplasmic surface as shown on the left-hand side of the slide.
In this conformation, the receptor can
efficiently interact with heterotrimeric G proteins,
which are the predominant class of signaling protein activated by GPCRs.
The G protein cell is composed of an alpha sub-unit and a beta-gamma dimer.
In its basal state, it's bound to a molecule of GTP.
When the stimulated receptor interacts with the G protein,
it catalyzes the dissociation of GTP from the alpha sub-unit.
GTP then binds due to its high cellular concentration.
This activates the G protein,
which causes it to dissociate from the receptor and triggers
the alpha and beta gamma sub-units to dissociate from one another.
These components are then in their active state and are able to
stimulate their respective downstream signaling cascades.
In the case of G alpha (s) ,
it activates adenylate cyclase,
which increases cyclic AMP concentrations within the cell.
The beta-gamma dimer regulates
other signaling proteins including kinases and ion channels.